Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jul 14 · below the Ichimoku cloud · RSI 48 · MACD above its signal
| 37.77 | 52-week high | +67.72% |
| 24.06 | R3 (classic) | +6.82% |
| 23.73 | R2 (classic) | +5.39% |
| 23.41 | Previous day high | +3.95% |
| 23.41 | Previous week high | +3.95% |
| 23.30 | Previous month high | +3.46% |
| 23.13 | R1 (classic) | +2.69% |
| 22.80 | Pivot | +1.26% |
| 22.52 | Price now | |
| 22.48 | Previous day low | −0.18% |
| 22.20 | S1 (classic) | −1.44% |
| 22.02 | Previous week low | −2.20% |
| 21.87 | S2 (classic) | −2.87% |
| 21.29 | Previous month low | −5.47% |
| 21.27 | S3 (classic) | −5.57% |
| 14.44 | 52-week low | −35.88% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $14.1M | 0.02% | 474.10K | −7.2% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a TCMD trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 9, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale at price 29.44 per share. | 11K | $323.24K |
| May 10, 2026 | Birkemeyer Elaine MChief Financial Officer | Sale at price 24.49 per share. | 4.6K | $113.40K |
| May 5, 2026 | Shafer David BrentDirector | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | Asbury Valerie L.Director | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | Washington Boyd VindellDirector | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | King Laura G.Director | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | Huggenberger Raymond ODirector | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | Burke William WDirector | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | Volkart Carmen BDirector | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| May 5, 2026 | Pearson AndreaDirector | Stock Award(Grant) at price 0.00 per share. | 6.5K | — |
| Mar 8, 2026 | Pearson AndreaDirector | Stock Award(Grant) at price 0.00 per share. | 852 | — |
| Feb 23, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale at price 28.94 per share. | 11K | $318.14K |
| Feb 23, 2026 | Burns KristieOfficer | Sale at price 28.94 per share. | 6.2K | $180.76K |
| Feb 23, 2026 | Birkemeyer Elaine MChief Financial Officer | Sale at price 28.94 per share. | 7.7K | $222.88K |
| Feb 22, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale at price 28.28 - 28.69 per share. | 15.2K | $431.25K |
| Feb 22, 2026 | Burns KristieOfficer | Sale at price 28.28 - 28.69 per share. | 4.4K | $125.61K |
| Feb 22, 2026 | Birkemeyer Elaine MChief Financial Officer | Sale at price 28.28 - 28.69 per share. | 5.5K | $156.14K |
| Feb 19, 2026 | Dodd Sheri LouiseChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 48K | — |
| Feb 19, 2026 | Burns KristieOfficer | Stock Award(Grant) at price 0.00 per share. | 14.7K | — |
| Feb 19, 2026 | Birkemeyer Elaine MChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 25.9K | — |
TimeframesUp on the monthly, down on the weekly, mixed on the hourly and daily.
pulling back under the 21 EMA
under a flat 21 EMA
under a falling 21 EMA, 21 under 50
over a rising 21 EMA, 21 over 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.5 | 1.5 | -10.8 | -11.9 | 6.9 | 21.0 | -5.4 | -18.4 | -3.0 | 1.0 | −22.3% | ||
| 2025 | 2.2 | -18.4 | -7.5 | 6.8 | -30.0 | 2.6 | -1.6 | 33.4 | 4.0 | 8.9 | 70.6 | 12.8 | +69.3% |
| 2024 | 6.1 | 0.5 | 6.6 | -15.3 | -7.6 | -6.2 | 7.0 | 7.2 | 6.7 | -0.7 | 34.7 | -12.3 | +19.8% |
| 2023 | 13.0 | 11.4 | 13.6 | 11.0 | 15.3 | 18.6 | -8.1 | -17.3 | -25.9 | -22.3 | 22.1 | 7.3 | +24.6% |
| 2022 | -17.1 | 29.1 | -1.0 | -16.3 | -39.8 | -28.1 | 6.2 | 6.5 | -5.6 | -4.5 | 15.1 | 34.1 | −39.7% |
| 2021 | 21.4 | -6.8 | 7.2 | 5.2 | -6.2 | -3.3 | -5.8 | -9.2 | -0.1 | -22.4 | -43.5 | -2.4 | −57.7% |
| 2020 | -16.8 | -10.3 | -20.3 | 28.5 | -6.1 | -14.5 | -1.1 | -6.2 | -4.8 | -0.0 | 17.9 | 4.2 | −33.4% |
| 2019 | 46.2 | 14.2 | -30.6 | -5.6 | -3.5 | 18.5 | 1.4 | -12.6 | -16.1 | 7.3 | 41.4 | 5.1 | +48.2% |
| 2018 | 8.8 | 2.6 | -1.7 | 9.5 | 42.6 | 4.8 | -7.6 | 40.8 | 5.0 | -7.8 | -14.1 | -19.0 | +57.2% |
| 2017 | -6.1 | 31.3 | -6.3 | -0.5 | 29.1 | 17.5 | 3.4 | 11.3 | -5.9 | -7.3 | 4.0 | -2.8 | +76.6% |
| 2016 | 29.0 | 28.7 | -5.0 | -8.1 | 0.5 | +45.7% |
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Buy / hold / sell counts